loader
Please Wait
Applying Filters...

Athena Athena

X

Technical details about Eperisone Hydrochloride, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
Also known as: 56839-43-1, Eperisone hcl, Myonal, Mional, Empp, Eperisone, hcl
Molecular Formula
C17H26ClNO
Molecular Weight
295.8  g/mol
InChI Key
GTAXGNCCEYZRII-UHFFFAOYSA-N
FDA UNII
U38O8U7P6X

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one;hydrochloride
2.1.2 InChI
InChI=1S/C17H25NO.ClH/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18;/h7-10,14H,3-6,11-13H2,1-2H3;1H
2.1.3 InChI Key
GTAXGNCCEYZRII-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2.Cl
2.2 Other Identifiers
2.2.1 UNII
U38O8U7P6X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (4'-ethyl-2-methyl-3-piperidino)propiophenone

2. 4-empp

3. E-0646

4. Eperisone

2.3.2 Depositor-Supplied Synonyms

1. 56839-43-1

2. Eperisone Hcl

3. Myonal

4. Mional

5. Empp

6. Eperisone, Hcl

7. E-646

8. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one Hydrochloride

9. Eperisone Hydrochloride [jan]

10. 4'-ethyl-2-methyl-3-piperidinopropiophenone Hydrochloride

11. U38o8u7p6x

12. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone Hydrochloride

13. 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one;hydrochloride

14. Dsstox_cid_27822

15. Dsstox_rid_82585

16. Dsstox_gsid_47844

17. Cas-56839-43-1

18. Ncgc00167973-01

19. (4'-ethyl-2-methyl-3-piperidino)propiophenone

20. Unii-u38o8u7p6x

21. E 0646

22. Epenard (tn)

23. 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, Hydrochloride

24. Eperisonehydrochloride

25. Dw-1030

26. Schembl218337

27. Chembl2360601

28. Dtxsid8047844

29. Eperisone Hydrochloride (jp17)

30. Chebi:31540

31. Bcp11969

32. Hy-b1901

33. Propiophenone, 4'-ethyl-2-methyl-3-piperidino-, Hydrochloride

34. Eperisone Hydrochloride [mi]

35. Tox21_112599

36. Mfcd00941459

37. Akos015843965

38. Tox21_112599_1

39. Ccg-267425

40. Eperisone Hydrochloride [mart.]

41. Ks-5241

42. Eperisone Hydrochloride [who-dd]

43. Ncgc00167973-02

44. Ac-15896

45. Db-052975

46. Cs-0013960

47. E2000

48. Ft-0602324

49. S4877

50. D01671

51. D95097

52. E-2000

53. A831198

54. Q27889924

55. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-onehydrochloride

56. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one Hydrochloride;eperisone Hcl

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 295.8 g/mol
Molecular Formula C17H26ClNO
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count5
Exact Mass295.1702921 g/mol
Monoisotopic Mass295.1702921 g/mol
Topological Polar Surface Area20.3 Ų
Heavy Atom Count20
Formal Charge0
Complexity275
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anticonvulsants

Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Calcium Channel Blockers

A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)


Muscle Relaxants, Central

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)


Parasympatholytics

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)


Post Enquiry
POST ENQUIRY